Page last updated: 2024-08-24

atorvastatin and Hyperuricemia

atorvastatin has been researched along with Hyperuricemia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Athyros, VG; Giouleme, O; Grammatikos, N; Katsoula, A; Paschos, P; Tsimperidis, A1
An, T; Hayashi, H; Kikkawa, A; Kose, E; Matsumoto, Y1
Derosa, G; Maffioli, P; Reiner, Ž; Sahebkar, A; Simental-Mendía, LE1
López-Cuenca, A; Marín, F; Roldán, V1

Reviews

2 review(s) available for atorvastatin and Hyperuricemia

ArticleYear
Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
    Current vascular pharmacology, 2018, Volume: 16, Issue:3

    Topics: Allopurinol; Atorvastatin; Biomarkers; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperuricemia; Non-alcoholic Fatty Liver Disease; Prevalence; Risk Factors; Treatment Outcome; Uric Acid

2018
Impact of Statin Therapy on Plasma Uric Acid Concentrations: A Systematic Review and Meta-Analysis.
    Drugs, 2016, Volume: 76, Issue:9

    Topics: Atorvastatin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperuricemia; Randomized Controlled Trials as Topic; Simvastatin; Uric Acid

2016

Trials

1 trial(s) available for atorvastatin and Hyperuricemia

ArticleYear
Hypouricemic effect of statins: another pleiotropic benefit?
    The Journal of thoracic and cardiovascular surgery, 2010, Volume: 139, Issue:5

    Topics: Atorvastatin; Biomarkers; C-Reactive Protein; Coronary Artery Bypass; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperuricemia; Lipids; Pyrroles; Time Factors; Treatment Outcome; Uric Acid

2010

Other Studies

1 other study(ies) available for atorvastatin and Hyperuricemia

ArticleYear
Effects on serum uric acid by difference of the renal protective effects with atorvastatin and rosuvastatin in chronic kidney disease patients.
    Biological & pharmaceutical bulletin, 2014, Volume: 37, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Female; Fluorobenzenes; Glomerular Filtration Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hyperuricemia; Kidney; Male; Middle Aged; Pyrimidines; Pyrroles; Renal Insufficiency, Chronic; Retrospective Studies; Rosuvastatin Calcium; Sulfonamides; Uric Acid

2014